Skip to main content

Study

Lutein Supplements May Improve Vision in Seniors With AMD

Taking lutein supplements can increase macular pigment and improve vision in older adults with age-related macular degeneration (AMD).

Eye HealthHealthy AgingSupplement
Study Credibility: High9.4/10From a trusted journalProperly designed studyResults verified
PublishedMay 2026Last reviewedMay 2026
Email this

Summary

In plain language

A recent analysis of multiple studies found that lutein supplements may benefit seniors with age-related macular degeneration (AMD). Researchers observed that taking lutein, a nutrient found in leafy greens, can boost macular pigment levels in the eye, which are linked to better vision. The study showed that after more than a year of supplementation, participants experienced improved visual acuity. This is promising news for older adults, as AMD is a leading cause of vision loss. While results are positive, it's important to discuss any new supplements with your healthcare provider to ensure they're right for you.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study reviewed nine controlled trials involving seniors with AMD who took lutein supplements compared to a placebo group.

  • Participants taking lutein showed an increase in macular pigment density and improved vision after more than a year.

  • The research included 855 participants and found improved outcomes even at higher doses in shorter periods.

  • While encouraging, the study notes the need for more long-term research to fully understand lutein's effects.

Discuss with your healthcare provider if lutein supplements could be beneficial for your eye health.

Research Quality Score

Scored May 10, 2026 using rubric v9_2026-04-08.

Assessment

This study is a high-quality meta-analysis of RCTs examining the effects of lutein supplementation on AMD, a condition affecting seniors. It follows rigorous methodological standards, including bias control and statistical integrity, and is highly relevant to the senior population. The study is transparent, with a registered protocol and clear conflict of interest disclosure.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication10.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study provides a comprehensive synthesis of existing RCTs, enhancing the reliability of its conclusions. It is well-suited for informing clinical decisions regarding lutein supplementation in seniors with AMD.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.